Delivery Order SPE2DB25D3202-SPE2DB26FSZFJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,538.21 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 150 micrograms on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded competitively. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,786.70 on May 8, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order is set to be completed by May 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Synthroid 175 mcg tablets (1,000 count) on September 19, 2025, with a ceiling value of $1,893.14 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Synthroid 50 MCG tablets in a 90-count configuration, with a contract ceiling value of $1,976.13. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without a set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,808.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on October 22, 2025, with completion scheduled for October 23, 2025. This competitive, non-set-aside award uses firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 1,000 tablets of Synthroid 150 micrograms with a ceiling value of $1,575.33. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for ultimate completion on September 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of 1,000 tablets of Synthroid 100 microgram at a ceiling value of $3,713.41. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of July 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's existing...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Synthroid 25 microgram tablets in quantities of 1,000 units. This firm fixed price delivery order carries a ceiling value of $8,685.79 and is scheduled for completion by October 27, 2025. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB26FSZFJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Synthroid 150 micrograms tablets in quantities of 1,000 units. This competitive award, valued at $1,308.24, represents a firm fixed price delivery order with an ultimate completion date of October 29, 2025. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, and carries no set-aside designation. This award is issued as a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Department of Defense and related healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering a wide range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order for Synthroid, a thyroid medication widely used in military and federal healthcare systems, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare programs through flexible contracting mechanisms designed to ensure consistent availability of essential pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/28/25 |